文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

静脉-静脉体外膜氧合启动时呼气末正压与急性呼吸窘迫综合征脱机结局的关联:一项多中心回顾性研究

Association Between Positive End-Expiratory Pressure at Venovenous Extracorporeal Membrane Oxygenation Initiation and Liberation Outcomes in Acute Respiratory Distress Syndrome: A Multicenter Retrospective Study.
PubMed 文献 · Crit Care Explor · 2026-02-05
一句话结论严重ARDS启动VV-ECMO时PEEP低于8 cm H2O与30天内成功脱机可能性降低相关,中高PEEP组间无显著差异。

该研究为J-CARVE登记数据的回顾性分析,纳入2012至2022年24家机构中接受VV-ECMO治疗的严重ARDS成人患者683例,按ECMO启动时PEEP分为低(<8 cm H2O)、中(8-10 cm H2O)、高(>10 cm H2O)三组。30天总体脱机率为69.2%,低、中、高PEEP组分别为57.8%(103/178)、73.5%(259/352)、72.5%(111/153)。多变量Cox模型调整后,低PEEP组成功脱机可能性显著低于中PEEP组(HR 0.56;95%CI 0.39-0.81),高PEEP组与中PEEP组无显著差异(HR 0.80;95%CI 0.58-1.10)。低PEEP组ECMO支持时间更长,但60天死亡率和住院时长组间无显著差异。作者认为应避免PEEP过低,并需前瞻性研究优化严重ARDS的PEEP策略。

要点

  • 严重ARDS启动VV-ECMO时PEEP<8 cm H2O组30天成功脱机率57.8%(103/178),低于中PEEP组73.5%(259/352)。
  • 调整后低PEEP组成功脱机可能性显著低于中PEEP组(HR 0.56;95%CI 0.39-0.81)。
  • 高PEEP组(>10 cm H2O)与中PEEP组(8-10 cm H2O)脱机可能性无显著差异(HR 0.80;95%CI 0.58-1.10)。
  • 低PEEP组ECMO支持时间更长,但60天死亡率和住院时长三组间无显著差异。
  • 作者认为应避免PEEP过低,并指出需前瞻性研究细化严重ARDS的PEEP策略。

适用人群与场景

  • 2012至2022年在24家机构接受VV-ECMO治疗的严重ARDS成人患者。

研究设计与关键结果

  • 研究类型为多中心回顾性研究(J-CARVE登记数据的post hoc分析),纳入683例严重ARDS成人患者,按ECMO启动时PEEP分为低(<8 cm H2O)、中(8-10 cm H2O)、高(>10 cm H2O)三组。
  • 30天总体ECMO脱机率为69.2%;低、中、高PEEP组脱机率分别为57.8%(103/178)、73.5%(259/352)、72.5%(111/153)。
  • 调整后低PEEP组成功脱机可能性显著低于中PEEP组(HR 0.56;95%CI 0.39-0.81);高PEEP组与中PEEP组无显著差异(HR 0.80;95%CI 0.58-1.10)。
  • 低PEEP组ECMO支持时间更长;60天死亡率和住院时长三组间无显著差异。

证据类型、等级与局限

  • 证据类型:多中心回顾性研究(J-CARVE登记数据的post hoc分析)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为应避免启动VV-ECMO时PEEP过低,并指出需前瞻性研究细化严重ARDS的PEEP策略。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: The optimal level of positive end-expiratory pressure (PEEP) during venovenous extracorporeal membrane oxygenation (ECMO) for acute respiratory distress syndrome (ARDS) remains uncertain.

OBJECTIVES: This study aimed to evaluate the association between initial PEEP settings at ECMO initiation and the rate of successful ECMO liberation in patients with severe ARDS.

DESIGN, SETTING, AND PARTICIPANTS: We conducted a post hoc analysis of the multicenter Japan Chest CT for ARDS Requiring Venovenous ECMO (J-CARVE) registry. Adult patients with severe ARDS treated with venovenous ECMO between 2012 and 2022 at 24 institutions were included. Participants were categorized into three groups according to PEEP at ECMO initiation: low (< 8 cm H2O), middle (8-10 cm H2O), and high (> 10 cm H2O).

MAIN OUTCOMES AND MEASURES: The primary outcome was successful liberation from ECMO within 30 days. Multivariable Cox proportional hazards models were used to evaluate associations. Secondary outcomes included 60-day mortality, duration of ECMO support, and duration of mechanical ventilation.

RESULTS: Among 683 patients analyzed, the overall ECMO liberation rate at 30 days was 69.2%. Liberation rates were 57.8% (103/178), 73.5% (259/352), and 72.5% (111/153) in the low, middle, and high PEEP groups, respectively. After adjustment, the low group had a significantly lower likelihood of successful ECMO liberation (hazard ratio [HR], 0.56; 95% CI, 0.39-0.81) compared with the middle group. No significant difference was observed between the high and middle groups (HR, 0.80; 95% CI, 0.58-1.10). The low group had longer ECMO duration; however, 60-day mortality and hospital length of stay did not differ significantly among groups.

CONCLUSIONS AND RELEVANCE: Lower PEEP levels at ECMO initiation were associated with reduced likelihood of successful ECMO liberation compared with moderate PEEP, whereas estimates for high vs. moderate PEEP were not statistically significant. These findings support avoiding insufficiently low PEEP and underscore the need for prospective studies to refine optimal PEEP strategies in patients with severe ARDS.

来源:Crit Care Explor,查看原文。版权归原作者所有。

参考来源

  1. Hongo T, Kosaki Y, Yumoto T, et al. Association Between Positive End-Expiratory Pressure at Venovenous Extracorporeal Membrane Oxygenation Initiation and Liberation Outcomes in Acute Respiratory Distress Syndrome: A Multicenter Retrospective Study. Crit Care Explor. 2026. PMID: 41642671. doi:10.1097/CCE.0000000000001375

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。